Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals-Reference-Cited by-同舟云学术

Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals

Published:2015-03 Issue:3 Volume:23 Page:591-601
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Morrow Matthew P,Tebas Pablo,Yan Jian,Ramirez Lorenzo,Slager Anna,Kraynyak Kim,Diehl Malissa,Shah Divya,Khan Amir,Lee Jessica,Boyer Jean,Kim J Joseph,Sardesai Niranjan Y,Weiner David B,Bagarazzi Mark L

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference43 articles.

1. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication;Lambotte;Clin Infect Dis,2005

2. Plasma human immunodeficiency virus RNA below 40 Copies/mL is rare in untreated persons even in the first years of infection;Lefrère;J Infect Dis,1999

3. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy;Deeks;Immunity,2007

4. Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors;Gaardbo;PLoS ONE,2013

5. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control;Migueles;Immunity,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancement in Polymer-based Carrier for DNA Vaccine;Current Pharmaceutical Design;2023-07

2. Methods to improve the immunogenicity of plasmid DNA vaccines;Drug Discovery Today;2021-11

3. Design, immunogenicity and efficacy of a Pan-SARS-CoV-2 synthetic DNA vaccine;2021-05-11

4. Therapeutic Vaccines for the Treatment of HIV;Translational Research;2020-09

5. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development;Expert Review of Clinical Pharmacology;2020-09-01